… fall, The Michael J. Fox Foundation (MJFF) held a workshop to address a budding, and potentially field-altering, … the   alpha-synuclein   protein implicated in PD might spread throughout the brain.  Today, the latest paper … field to catch up, and potentially, to even leapfrog, where we are in Alzheimer’s research.”  Nate Herpich …

… Objective: Our objective is to identify known, safe drugs that are useful for treating … such as enzymes, cell receptors, and DNA. Recently it has become clear that many drugs interact strongly with more than … We have therefore developed a computational method to predict whether a drug is likely to be active against a …

… option for another. But as more and more patients and doctors incorporate new drugs into their regular treatment … (If you participated, we thank you!) Researchers presented the results today at the annual International … drug maker, but some use their own strategies. The time to complete the switch also varied widely from overnight to …

… Age quackery. For others, it’s a source of hope and a way to reconcile their spiritual life with modern science. For … that there is not a single placebo effect, but many. One common effect involves the assumption that a particular pill … convince himself of something,” Dr. Rose said. “He doesn’t buy it because someone else does it. He is a skeptic. But …

… that guide protein movement around cells, are linked to Parkinson's disease (PD). We have identified a group of … of contact between neurons (called synapses) and thereby prevent defects in neuronal communication that occur in PD from alpha-synuclein …

… “I’ve been lucky,” he says. “Parkinson’s has been kind to me,” and he’s continued to work at NASA in Huntsville, … Also speaking at the U.S. Space & Rocket Center will be representatives from Serina Therapeutics, a biotech firm … says David. “But once they learn more, I believe they’ll be compelled to help do their part for the cause.” While …